If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro™ (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can patients use tirzepatide if they have undergone or are awaiting an organ transplant?
No information is available for patients who have undergone or are awaiting an organ transplant.
See important safety information, including boxed warning, in the attached prescribing information.
No information is available on the use of tirzepatide in patients who have a transplanted organ or who are awaiting an organ transplant. However, patients with corneal transplants were eligible to participate in the SURPASS clinical trial program.
Enclosed Prescribing Information
Date of Last Review: May 13, 2022